Theratechnologies EV/Sales
Was ist das EV/Sales von Theratechnologies?
EV/Sales von Theratechnologies, Inc. ist 1.52
Was ist die Definition von EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales von Unternehmen in Health Care Sektor auf TSX im Vergleich zu Theratechnologies
Was macht Theratechnologies?
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Unternehmen mit ev/sales ähnlich Theratechnologies
- CK Hutchison hat EV/Sales von 1.52
- Olin hat EV/Sales von 1.52
- Bank of Communications Co hat EV/Sales von 1.52
- Apollo Healthcare hat EV/Sales von 1.52
- Obsidian hat EV/Sales von 1.52
- Religare Enterprises hat EV/Sales von 1.52
- Theratechnologies hat EV/Sales von 1.52
- LafargeHolcim hat EV/Sales von 1.52
- CLS USA hat EV/Sales von 1.52
- Himadri Speciality Chemical hat EV/Sales von 1.52
- Lever Style Corp hat EV/Sales von 1.52
- Pricol hat EV/Sales von 1.52
- Apollo Healthcare hat EV/Sales von 1.52